The bacterial surface expression of SARS viral epitope using Salmonella typhi cytolysin A

Journal of Bacteriology and Virology

Volumn 39, Issue 2, 2009, Pages 103-112

  Piao, Hong Hua ^a   Seong, Jihyoun ^a   Song, Man Ki ^b   Kim, Youn Uck ^c   Shin, Dong Jun ^a   Choy, Hyon E ^a   Hong, Yeongjin ^a  

^a Chonnam National University Medical School   (South Korea)

^b International Vaccine Institute   (South Korea)

^c SunMoon University   (South Korea)

Author keywords

Cytolysin A; SARS; Surface display

Indexed keywords

CYTOLYSIN; CYTOLYSIN A; DIAMINOPIMELIC ACID; EPITOPE; SEVERE ACUTE RESPIRATORY SYNDROME VACCINE; UNCLASSIFIED DRUG; VIRUS SPIKE PROTEIN; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM TRANSFORMATION; CONTROLLED STUDY; CYTOTOXICITY; EXPRESSION VECTOR; FEMALE; GENE DELIVERY SYSTEM; GENE EXPRESSION SYSTEM; HELA CELL; HEMOLYSIS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NONHUMAN; SALMONELLA TYPHI; SALMONELLA TYPHIMURIUM; SARS CORONAVIRUS; VACCINE PRODUCTION; WESTERN BLOTTING;

BACTERIA (MICROORGANISMS); ENTEROBACTERIACEAE; MUS; SALMONELLA TYPHI; SARS CORONAVIRUS;

EID: 77649275070     PISSN: 15982467     EISSN: None     Source Type: Journal    
DOI: 10.4167/jbv.2009.39.2.103     Document Type: Article

References (23)

1. Garmory HS, Brown KA, Titball RW. Salmonella vaccines for use in humans: present and future perspectives. FEMS Microbiol Rev 2002;26:339-53.
2. Garmory HS, Leary SE, Griffin KF, Williamson ED, Brown KA, Titball RW. The use of live attenuated bacteria as a delivery system for heterologous antigens. J Drug Target 2003;11:471-9.
3. Kochi SK, Killeen KP, Ryan US. Advances in the development of bacterial vector technology. Expert Rev Vaccines 2003;2:31-43.
4. Lee JS, Shin KS, Pan JG, Kim CJ. Surface-displayed viral antigens on Salmonella carrier vaccine. Nat Biotechnol 2000;18:645-8.
5. Gentschev I, Dietrich G, Goebel W. The E. coli alphahemolysin secretion system and its use in vaccine development. Trends Microbiol 2002;10:39-45.
6. Zhu C, Ruiz-Perez F, Yang Z, Mao Y, Hackethal VL, Greco KM, Choy W, Davis K, Butterton JR, Boedeker EC. Delivery of heterologous protein antigens via hemolysin or autotransporter systems by an attenuated ler mutant of rabbit enteropathogenic Escherichia coli. Vaccine 2006;24:3821-31.
7. Wallace AJ, Stillman TJ, Atkins A, Jamieson SJ, Bullough PA, Green J, Artymiuk PJ. E. coli hemolysin E (HlyE, ClyA, SheA): X-ray crystal structure of the toxin and observation of membrane pores by electron microscopy. Cell 2000;100:265-76.
8. Wai SN, Lindmark B, Söderblom T, Takade A, Westermark M, Oscarsson J, Jass J, Richter-Dahlfors A, Mizunoe Y, Uhlin BE. Vesicle-mediated export and assembly of pore-forming oligomers of the enterobacterial ClyA cytotoxin. Cell 2003;115:25-35.
9. del Castillo FJ, Moreno F, del Castillo I. Secretion of the Escherichia coli K-12 SheA hemolysin is independent of its cytolytic activity. FEMS Microbiol Lett 2001;204:281-5.
10. Galen JE, Zhao L, Chinchilla M, Wang JY, Pasetti MF, Green J, Levine MM. Adaptation of the endogenous Salmonella enterica serovar Typhi clyA-encoded hemolysin for antigen export enhances the immunogenicity of anthrax protective antigen domain 4 expressed by the attenuated live-vector vaccine strain CVD 908-htrA. Infect Immun 2004;72:7096-106.
11. Spiga O, Bernini A, Ciutti A, Chiellini S, Menciassi N, Finetti F, Causarono V, Anselmi F, Prischi F, Niccolai N. Molecular modelling of S1 and S2 subunits of SARS coronavirus spike glycoprotein. Biochem Biophys Res Commun 2003;310:78-83.
12. Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough TC, Choe H, Farzan M. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003;426:450-4.
13. Wong SK, Li W, Moore MJ, Choe H, Farzan M. A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2. J Biol Chem 2004;279:3197-201.
14. He Y, Zhou Y, Liu S, Kou Z, Li W, Farzan M, Jiang S. Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine. Biochem Biophys Res Commun 2004;324:773-81.
15. Valle E, Guiney DG. Characterization of Salmonella-induced cell death in human macrophage-like THP-1 cells. Infect Immun 2005;73:2835-40.
16. Kang HY, Srinivasan J, Curtiss R 3rd. Immune responses to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar typhimurium vaccine. Infect Immun 2002;70:1739-49.
17. Song M, Kim HJ, Kim EY, Shin M, Lee HC, Hong Y, Rhee JH, Yoon H, Ryu S, Lim S, Choy HE. ppGpp-dependent stationary phase induction of genes on Salmonella pathogenicity island 1. J Biol Chem 2004; 279:34183-90.
18. Galan JE, Nakayama K, Curtiss R 3rd. Cloning and characterization of the asd gene of Salmonella typhimurium: use in stable maintenance of recombinant plasmids in Salmonella vaccine strains. Gene 1990; 94:29-35.
19. Nayak AR, Tinge SA, Tart RC, McDaniel LS, Briles DE, Curtiss R 3rd. A live recombinant avirulent oral Salmonella vaccine expressing pneumococcal surface protein A induces protective responses against Streptococcus pneumoniae. Infect Immun 1998; 66:3744-51.
20. Na HS, Kim HJ, Lee HC, Hong Y, Rhee JH, Choy HE. Immune response induced by Salmonella typhimurium defective in ppGpp synthesis. Vaccine 2006;24:2027-34.
21. Westermark M, Oscarsson J, Mizunoe Y, Urbonaviciene J, Uhlin BE. Silencing and activation of ClyA cytotoxin expression in Escherichia coli. J Bacteriol 2000; 182: 6347-57.
22. Morales C, Lee MD, Hofacre C, Maurer JJ. Detection of a novel virulence gene and a Salmonella virulence homologue among Escherichia coli isolated from broiler chickens. Foodborne Pathog Dis 2004;1:160-5.
23. Lai XH, Arencibia I, Johansson A, Wai SN, Oscarsson J, Kalfas S, Sundqvist KG, Mizunoe Y, Sjöstedt A, Uhlin BE. Cytocidal and apoptotic effects of the ClyA protein from Escherichia coli on primary and cultured monocytes and macrophages. Infect Immun 2000;68: 4363-7.